Clinical Trials Logo

Filter by:
NCT ID: NCT04846374 Completed - Apheresis Clinical Trials

Two is Better Than One: A Novel Venous Access System for Intermittent Apheresis

Start date: May 26, 2021
Phase:
Study type: Observational

Purpose: To describe a novel configuration of venous access for the performance of intermittent apheresis. Participants: 20 participants at UNC who were referred for change from a vortex port to a powerflow port. Procedures (methods): Placement of one of two configurations of the powerflow port and follow up visits between January 1, 2019 and December 31, 2023.

NCT ID: NCT04846322 Completed - Dementia Clinical Trials

Pathway to Detection & Differentiation of Delirium & Dementia in the Emergency Department

IMPACT
Start date: March 1, 2021
Phase:
Study type: Observational

This is an observational study of the pragmatic implementation of an ED screening, outpatient referral, and care coordination process for older ED patients who may have UCID.

NCT ID: NCT04846231 Completed - Clinical trials for Hypercholesterolemia

Supplements, Placebo, or Rosuvastatin Study

SPORT
Start date: April 23, 2021
Phase: Phase 2
Study type: Interventional

A research study that is evaluating a low dose of an FDA approved statin medication in comparison to several commercially available over the counter dietary supplements which are marketed for cholesterol health. The study is comparing their effect on LDL cholesterol. LDL-cholesterol is low-density cholesterol and is sometimes referred to as "bad" cholesterol. Participants must live in Ohio and have a documented elevated LDL cholesterol level between 70-189mg/dL, must not currently be taking a statin or one of the dietary supplements included in the trial. Participants willing to discontinue a prohibited supplement for 4 weeks prior to enrollment will be allowed to participate. Trial participation is 4 weeks. Study medication will be provided at no charge. There will be 2 visits which include a lab draw at any Cleveland Clinic laboratory. Participants will be randomized (like a coin flip) to be in one of 8 possible groups: Rosuvastatin, Fish oil, Cinnamon, Garlic, Turmeric, Plant sterol, Red yeast rice, or placebo. The study will enroll 200 participants.

NCT ID: NCT04846088 Completed - Tobacco Use Clinical Trials

A Study to Characterize Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouches in Adult Cigarette Smokers

Start date: April 5, 2021
Phase: N/A
Study type: Interventional

This study is designed to evaluate plasma nicotine pharmacokinetic (PK) parameters following the use of nicotine pouches in cigarette smokers who have experience with use of smokeless tobacco (SST) [e.g., snus, moist snuff].

NCT ID: NCT04845906 Completed - Clinical trials for Peripheral Intravenous Catheter Stabilization

A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices

Start date: July 13, 2021
Phase:
Study type: Observational

This study is a prospective healthy human volunteer wear study to evaluate the safety and performance of the StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device Accessory (Foam Strip) and to meet the design input requirements.

NCT ID: NCT04845776 Completed - Clinical trials for Autism Spectrum Disorder

Vitamin/Mineral Supplement for Children With Autism

Start date: May 4, 2021
Phase: N/A
Study type: Interventional

This is an open-label 3 month clinical trial of a vitamin/mineral supplement designed for children with autism.

NCT ID: NCT04845646 Completed - Healthy Clinical Trials

DDI Study of ASC41 in HV and the PK, Safety and Tolerability in Subjects With NAFLD.

Start date: March 16, 2021
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to evaluate the effect of itraconazole, a strong inhibitor)of cytochrome P4503A , and phenytoin a strong inducer of cytochrome P450 3A, CYP3A4, CYP1A2 and CYP2C19 on the pharmacokinetics of ASC41, a THR beta agonist tables in healthy subjects. The PK, Safety and Tolerability of ASC 41 in Subjects with NAFLD will also be evaluated. Approximately 24 subjects including 16 healthy volunteers (HVs) and 8 subjects with NAFLD will be enrolled. This study consists of 3 cohorts.

NCT ID: NCT04845620 Completed - Clinical trials for Atopic Dermatitis Eczema

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)

Start date: April 7, 2021
Phase: Phase 3
Study type: Interventional

This study will assess the safety and efficacy of ARQ-151 cream vs vehicle applied once a day for 4 weeks by subjects with atopic dermatitis (eczema).

NCT ID: NCT04845568 Completed - Childhood Obesity Clinical Trials

Testing Digital Technologies to Help Families Build Healthy Habits

Start date: April 17, 2021
Phase: N/A
Study type: Interventional

The current study is a randomized pilot trial to test the feasibility of a psychoeducational virtual reality experience to increase motivation for behavior change among children with overweight or obesity.

NCT ID: NCT04845451 Completed - Cluster Headache Clinical Trials

The Presence and Role of Zygomatic-temporal Neuroma Triggering Cluster Headache

Start date: June 9, 2021
Phase:
Study type: Observational

Role of a neuroma of zygomatic-temporal in triggering of a cluster headache. Exploratory diagnosis, resection, and pathological examination of tumor anticipated .